Articles From: Celsion Announces The Unexpected Passing of Max E. Link, Ph.D., Chairman of the Board to Cemtrex Receives $3 Million in New Orders


LAWRENCEVILLE, N.J. , Oct.
Sign-up for Celsion Announces The Unexpected Passing of Max E. Link, Ph.D., Chairman of the Board investment picks
LAWRENCEVILLE, N.J. , Nov.
Sign-up for Celsion Corporation Receives VHP Approval to Initiate OPTIMA Study in Europe investment picks
2014/11/11
Company Completes Acquisition and Integration of EGEN, Inc.; Enrollment Underway in Phase III OPTIMA Study; Initiates Phase II Euro-DIGINTY Study for RCW Breast Cancer; Establishes Clinical Study Plans for EGEN-001 Company to Hold Conference Call on Tuesday, November 11, 2014 at 4:30 p.m. ET LAWRENCEVILLE, N.J. , Nov.
Sign-up for Celsion Corporation Reports Third Quarter 2014 Financial Results investment picks
Data Supportive of GEN-2, an RNAi Carrier for Therapeutic Treatment of Lung Cancer LAWRENCEVILLE, N.J. , Oct.
Sign-up for Celsion Presents Preclinical Data for its TheraSilence™ Platform at the miRNA World Conference Workshop on miRNA Delivery investment picks
ThermoDox® Combined with Mild Local Hyperthermia is Safe and Produces Compelling Objective Local Responses in RCW Breast Cancer Patients Reinforces Current Phase II Interim Response Rates in Heavily Pretreated Patients, Further Supporting Continued Development Plans LAWRENCEVILLE, N.J. , Sept.
Sign-up for Celsion Reports Consolidated Duke University and Celsion's DIGNITY Study Clinical Data on ThermoDox® in Recurrent Chest Wall Breast Cancer Published in the International Journal of Hyperthermia investment picks
LAWRENCEVILLE, N.J. , Aug.
Sign-up for Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference investment picks
2014/10/24
Cementos Pacasmayo S.A.A. (NYSE:CPAC; BVL:CPACASC1) (“the Company” or “Cementos Pacasmayo”) announced today that at a Board meeting held on October 23, 2014, the Company's Board of Directors approved a cash dividend of S/. 0.20 per common and investment share, which represents a total of S/. 116,392,920.60 related to retained earnings as of December 31, 2013, in accordance with what was authorized at the Annual Shareholder’s Meeting on March 25, 2014.
Sign-up for Cementos Pacasmayo S.A.A. Announces Annual Dividend Payment investment picks
2014/10/27
Cementos Pacasmayo S.A.A. and subsidiaries (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Cementos Pacasmayo”) a Peruvian cement company, announced today its consolidated results for the third quarter (“3Q14”) and nine months (“9M14”) ended September 30, 2014.
Sign-up for Cementos Pacasmayo S.A.A. Announces Consolidated Results for Third Quarter 2014 investment picks
2014/10/24
LIMA, Peru , Oct.
Sign-up for Cementos Pacasmayo to host Third Quarter 2014 Earnings Conference Call & Audio Webcast investment picks
2014/10/30
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that it has signed binding agreements with Holcim regarding the series of transactions originally announced on August 28, 2013.
Sign-up for CEMEX and Holcim Agree on Series of Transactions in Europe investment picks
2014/10/2
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today the expiration of its previously announced cash tender offer (the “Tender Offer”) to purchase up to U.S.$1,175 million of the 9.000% Senior Secured Notes due 2018 (the “2018 Notes”) issued by CEMEX and the 9.250% Senior Secured Notes due 2020 (the “2020 Notes” and, together with the 2018 Notes, the “Notes”) issued by CEMEX España, S.A., acting through its Luxembourg Branch.
Sign-up for CEMEX Announces Expiration and Final Settlement of its Tender Offer for Certain Senior Secured Notes investment picks
2014/9/4
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE:CX) announced today its intention to offer senior secured notes in one or more series denominated in Euros (the “Euro Notes”), subject to market and other conditions.
Sign-up for CEMEX Announces Offering of Senior Secured Notes investment picks
2014/9/26
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today the pricing of its private offering of 200,000 Contingent Convertible Units, each with a stated amount of U.S.$1,000. The Contingent Convertible Units are intended to finance payment of the principal amount of U.S.$200 million of CEMEX’s 4.875% Convertible Subordinated Notes due 2015 (the “2015 Existing Convertible Notes”) that mature without conversion.
Sign-up for CEMEX Announces Pricing of U.S.$200 Million in Contingent Convertible Units investment picks
2014/11/3
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that it has received U.S.$515 million of commitments from banks that have agreed to join the credit agreement entered into on September 30, 2014 (the “Credit Agreement”). Following the completion of customary closing conditions, the banks that provided the new commitments will accede the Credit Agreement as additional lenders, increasing the total amount of the Credit Agreement from U.S.$1.35 billion to U.S.$1.87 billion.
Sign-up for CEMEX Increases New Bank Loan to U.S.$1.87 Billion and Successfully Concludes Amendment to Facilities Agreement investment picks
2014/9/30
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that it has entered into a new credit agreement for U.S.$1.35 billion (the "Credit Agreement"), with nine of the main lending banks from its Facilities Agreement dated September 17, 2012 (as amended from time to time, the "Facilities Agreement".) The main terms of the new Credit Agreement, which represent an improvement over the main terms of the existing Facilities Agreement, are as follows: An average 4-year term with equal semi-annual payments of principal of 20% each, beginning on the third anniversary of the Credit Agreement and with the last payment on September 2019.
Sign-up for CEMEX Obtains New Bank Loan under Improved Conditions investment picks
2014/10/23
CEMEX, S.A.B. de C.V. ("CEMEX") (NYSE: CX), announced today that consolidated net sales reached approximately U.S.$4.1 billion during the third quarter of 2014, an increase of 4% on a like-to-like basis for the ongoing operations and adjusting for currency fluctuations, versus the comparable period in 2013.
Sign-up for CEMEX Reports Third-Quarter 2014 Results investment picks
2014/10/30
By Chester Yung Global building material company Cemex S.A.B. de C.V. (CEMEX.MX) said Thursday it will buy all of Holcim Ltd's.
Sign-up for Cemex Signs Deal to Buy Holcim's Czech Assets, Divest of Assets in Western Germany to Holcim investment picks
CHAPEL HILL, N.C., Sept.
Sign-up for Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial investment picks
- Qualified Infectious Disease Product (QIDP) Granted for Solithromycin Capsules by the FDA - CHAPEL HILL, N.C., Aug.
Sign-up for Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection investment picks
CHAPEL HILL, N.C., Oct.
Sign-up for Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
CHAPEL HILL, N.C., Nov.
Sign-up for Cempra to Present at Two Upcoming Investor Conferences investment picks
$16.0 Million Will be Provided to Cover the Cost of the Study and Other Activities Specified in the Contract CHAPEL HILL, N.C., Nov.
Sign-up for Cempra to Receive BARDA Funding for 1b and Start-Up of Phase 2/3 Solithromycin Pediatric Studies investment picks
CHAPEL HILL, N.C., Aug.
Sign-up for Cempra, Inc. to Present at Three Investor Conferences investment picks
FARMINGDALE, N.Y. , Sept.
Sign-up for Cemtrex and MODCON to Present at Upcoming 4th Opportunity Crudes Conference September 15 in Houston investment picks
FARMINGDALE, N.Y. , Nov.
Sign-up for Cemtrex Announces 2014 Annual Results: Sales Increase by 249% investment picks
2014/9/18
FARMINGDALE, N.Y. , Sept.
Sign-up for Cemtrex Chairman and CEO Issues Interim Annual Letter to Shareholders investment picks
2014/10/28
FARMINGDALE, N.Y. , Oct.
Sign-up for Cemtrex Receives $3 Million in New Orders investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Celsion Announces The Unexpected Passing of Max E. Link, Ph.D., Chairman of the Board to Cemtrex Receives $3 Million in New Orders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent